UNIVERSAL THERAPEUTICS PARTNERS DOCTORONCALL FOR STRATEGIC DISTRIBUTION
UNIVERSAL THERAPEUTICS PARTNERS DOCTORONCALL FOR STRATEGIC DISTRIBUTION AND ADMINISTRATION OF COVID-19 SELF-TEST KITS IN MALAYSIA
KUALA LUMPUR, Malaysia, Oct 18 (Bernama) -- Universal Therapeutics, a multinational pharmaceutical and biotech company based in Malaysia, today announced its partnership with DoctorOnCall, Malaysia’s first and largest digital health platform. Consumers can now visit DoctorOnCall’s website and purchase COVID-19 self-test kits at a transparent, fixed price, and have the kits delivered to their homes.
The partnership addresses the prevalent issue of errant distribution and inconsistent price points of COVID-19 self-test kits in Malaysia.
“Our focus has always been on providing safe and high-quality pharmaceutical and medical products to enhance people’s health and quality of life,” said Sidney Soares, Chief Executive Officer of Universal Therapeutics. “Being able to do so through responsible partners, such as DoctorOnCall, is extremely important to us, so as to ensure that our consumers and patients continue to receive the best care that they need.”
“We resonate with Universal Therapeutics’ mission of providing safe and excellent medical products,” said Hazwan Najib, Co-Founder of DoctorOnCall Malaysia. “In fact, DoctorOnCall was founded to provide quality and affordable healthcare to Malaysians. We reduce waiting time at clinics and hospitals by shifting health consultations online. It is especially critical to provide this service now via a telehealth platform, considering the current pandemic. We are proud to be working with Universal Therapeutics to bring COVID-19 self-test kits to more consumers via our online platform, and look forward to continuing this strong partnership.”
Universal Therapeutics and DoctorOnCall are both committed to aiding the healthcare sector in Malaysia continue their battle against the COVID-19 virus.
Kommentare